{"id":1016060,"date":"2026-11-02T09:37:35","date_gmt":"2026-11-02T14:37:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/"},"modified":"2026-11-02T09:37:35","modified_gmt":"2026-11-02T14:37:35","slug":"cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/","title":{"rendered":"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Calif., Nov.  02, 2026  (GLOBE NEWSWIRE) &#8212; Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three upcoming presentations, including two Late Breaking Oral Abstract presentations and one poster presentation, at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions, held in collaboration with the American Heart Association Scientific Sessions, taking place in Chicago, IL, November 6, 2026.<\/p>\n<p>\n        <strong>Late-Breaking Oral Abstracts <\/strong>\n      <\/p>\n<p>\n        <strong>Title:<\/strong><br \/>\n        <strong>Effect of <\/strong><br \/>\n        <strong><br \/>\n          <em>Aficamten<\/em><br \/>\n        <\/strong><br \/>\n        <strong> on Cardiac Structure and Function in Nonobstructive Hypertrophic Cardiomyopathy: The ACACIA-HCM CMR Study<br \/><\/strong><br \/>\n        <strong>Presenter<\/strong>: Ahmad Masri, M.D., M.S., Associate Professor of Medicine, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health &amp; Science University<br \/><strong>Date<\/strong>: Friday, November 6, 2026<br \/><strong>Session Title<\/strong>: Session 4 &#8211; Late Breaking Oral Abstracts<br \/><strong>Session Time<\/strong>: 2:15 PM \u2013 3:15 PM CT <br \/><strong>Presentation Time<\/strong>: 2:30 PM \u2013 2:40 PM CT<br \/><strong>Location<\/strong>: Room S406a<\/p>\n<p>\n        <strong>Title: Effect of\u00a0<\/strong><br \/>\n        <strong><br \/>\n          <em>Aficamten<\/em><br \/>\n        <\/strong><br \/>\n        <strong> on Patient-Reported Health Status in Non-Obstructive Hypertrophic Cardiomyopathy<\/strong><br \/>\n        <br \/>\n        <strong>Presenter<\/strong>: Michael E. Nassif, M.D., Cardiologist, Saint Luke\u2019s Mid America Heart Institute<br \/><strong>Date<\/strong>: Friday, November 6, 2026<br \/><strong>Session Title<\/strong>: Session 4 \u2013 Late Breaking Oral Abstracts<br \/><strong>Session Time: <\/strong>2:15 PM &#8211; 3:15 PM CT<br \/><strong>Presentation Time:<\/strong> 2:45 PM -2:55 PM CT<br \/><strong>Location<\/strong>: Room S406A<\/p>\n<p>\n        <strong>Poster Presentation<\/strong>\n      <\/p>\n<p>\n        <strong>Title: Left Ventricular Systolic Dysfunction in Long-Term <\/strong><br \/>\n        <strong><br \/>\n          <em>Aficamten<\/em><br \/>\n        <\/strong><br \/>\n        <strong> Therapy for Obstructive HCM: A FOREST-HCM Analysis<\/strong><br \/>\n        <br \/>\n        <strong>Presenter<\/strong>: Daniele Massera, M.D., Director, Hypertrophic Cardiomyopathy Program, NYU Langone Health, Assistant Professor, Department of Medicine, NYU Grossman School of Medicine<br \/><strong>Date<\/strong>: November 6, 2026 <br \/><strong>Session Title<\/strong>: Poster Reception<br \/><strong>Session Time<\/strong>: 5:30 PM &#8211; 6:30 PM CT<br \/><strong>Presentation Time: <\/strong>5:30 PM &#8211; 6:30 PM CT<br \/><strong>Location<\/strong>: Room S406B<\/p>\n<p align=\"justify\">\n        <strong>About Cytokinetics<\/strong>\n      <\/p>\n<p align=\"justify\">Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction. Cytokinetics\u2019 MYQORZO<sup>\u00ae<\/sup> (<em>aficamten<\/em>) is a cardiac myosin inhibitor approved in the U.S., China, European Union, United Kingdom and Canada for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Following positive topline results in ACACIA-HCM, a Phase 3 clinical trial of <em>aficamten<\/em> in patients with non-obstructive HCM (nHCM), the company plans to submit a Supplemental New Drug Application in Q4 2026. Cytokinetics is also developing <em>omecamtiv mecarbil<\/em>, an investigational cardiac myosin activator for the potential treatment of patients with heart failure with severely reduced ejection fraction and <em>ulacamten<\/em>, an investigational cardiac myosin inhibitor for the potential treatment of heart failure with preserved ejection fraction, while continuing pre-clinical research and development in muscle biology.<\/p>\n<p align=\"justify\">For additional information about Cytokinetics, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=QSof98VJzGuU86LFpjwfNlzQFP00ej-R-qXKLaHny6aQqHCLlbl5HRjgF7yPUkr4I1_ekqDekzVC4ctIfYmuTlAJ1nTPujC55PuX0BRMl3A=\" rel=\"nofollow\" target=\"_blank\"><u>www.cytokinetics.com<\/u><\/a> and follow us on <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nDXwOGmeN0oneb-spzHFr31f--grHfsz5XgSpsnxuXAMUktg_qjil-ijVAh9yltWjQ0_jJOF9d1R9YBQyjFDXzF0KcozkN6iO4cv-SD_gl8PXQ1y5WIHnSe9JRhAuHvpAuXiaHw2kru7lHM5uBOg8tF2ITZn5wNoRj07n7xsKixFbc6PB7IqOi2OdjVgJ6iZsgk8IF-dB71tRgZPWhPnQDOxaktIpmxOJJefUQayDg3PAlu7eQWdvmqvhV2-dZpQH4nRHG1_5cEWjcXIHgZjKZQLbhsLLjLjbmAeBDYA9Riwc3nW9QkhVHYs6mF4HrY7jzfSYpivIeucpdgkm_qZ4-eOElhZ0W1gZJ5U2pyxgJ1yimA9efUKcqweKYZ_2h72\" rel=\"nofollow\" target=\"_blank\"><u>X<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WJ5yETusSEZ8qvp_KfUEHOLTmfBQtz5kqvLtFwQQq5RF7L31DBpCBdUYeqNotSQTjRek-qRY_cHs_drBn2lnXs8KRNPAPs1hOmMZp7kTS16QBjp41Vg66IXpi1IK1BxzMYXdFqxZWVY2bYXdybMe5iug5WUvBwzB0-A9fHvj1c5BJhufhBzkKqUQnJCIWxsBjjzzfx9qsRPxTQH7H5J1ymvt2F8UTk3Kg668buWtrZkTK6-rZMQvYXaVplX6yrEygDZkCdMv6FODUfS89sgW0S2iNknYraTh938p1WVnKMIoCqsCZXiBu4AWH9mifvtZrY8lFJRR7do1FwObei0Gndppldwuza8F36-03Kki-O9SUcLlNrmwuH4_L-O9iIKoEz7snaiJJbOoU5bWQB9pUQFA-YSa1NhewoXbFSF1NqxzXKyE8SPAG9MhvkMPk34HJvpNcBm4kqzwz1zUfqXN41o5lezWCiHPL6N_ZN7OT8g=\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>, <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=P0954NG3dw8tQy_Pvg1hzA9U7aQbff1x0KHiTdGdW9VSUq6VJRkXz6XjnBKP7B0ZMjFRtQmMHNnlTES8FgXi8nxI1pAe4NqhgFAfsb69jdaUXz3NJmYGfQLz_Vyo2xmOO1cmDcYdtwhzkJhXa-8ETG0IWQFVpTY-Qk443zX5tuSSP-MMvqgMW-fW8L8y58Oq_T9PveOnZOqFlu4gIwXPbvzPPF0nqrU_3hMWCNjhBzAvY6qksfI7czd0-mo_EdcM6A_E-PtAn06-B6yJV0Y0FGNQ3XvsOZK8akgEKPzyppGC-v9tH6w7u4CjAcFMhnfPAWSnrSCl1IOqogrRwiDyZ1SYA4jxzHeKjhEI7_qKhhQyvdsrNQD9PAO4MRZMz0hWyxhBk80mg-sZf3CrYA-p90qAtbNCT1NUFMaL2XcPzODrB9cst8fEOwse6Ny6m7Jg\" rel=\"nofollow\" target=\"_blank\"><u>Facebook<\/u><\/a> and <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h9Od_voJZdxVs0t_G43KbF-TOoO3TA-XaZymigLG-Z0uXf4LtsL4A1TUpET7a2iX2aMVgDSR6QySPFmllQxKVoaQfvS-LL2-BeFCAAXjzaydLBmDPdCviOOB-UjEvYSTXeYopXOy98TKHRlvLaWVWRU79bcHl13CpsnfJXLJkeS917N8XRbrKDDu-7bPvds9zrJsWbzdsNJ4qOTT7GKPDqps_awpoN9h7im5IFzm0RaBpUZ2QTHitAPb5-kvYuLBZy2hKrYMyNtHe5y6W812DkCzLo4ncj22UnfEiEKOBIG48JuOTWiPsRVvr-qjMRLcwELPXjcJO-3nlmSmQzhNm_P82pWEOf4audHU9w92rhtN8fpKBsswe08Ho3KPapzPINoYI7ZlQCfU9MYy39nDetdFSgBrASLfOpBMDAEB4b6bcmTARi-vJ_zCpjhoBch4o-PAU0DJPFywgIM5A_8WjmaOd4_tE5-32UYwaS2cfj8=\" rel=\"nofollow\" target=\"_blank\"><u>YouTube<\/u><\/a>.<\/p>\n<p align=\"justify\">\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains forward-looking statements for purposes of the Private Securities Litigation Reform Act of 1995 (the \u201cAct\u201d). Cytokinetics disclaims any intent or obligation to update these forward-looking statements and claims the protection of the Act\u2019s Safe Harbor for forward-looking statements. Examples of such statements include, but are not limited to, statements relating to our ability to obtain regulatory approval for <em>aficamten<\/em> in nonobstructive hypertrophic cardiomyopathy in any jurisdiction by any particular date, if ever, the number of patients comprising the eligible treatment population for <em>aficamten<\/em>, or market acceptance of <em>aficamten<\/em> for the treatment of nonobstructive hypertrophic cardiomyopathy. Such statements are based on management\u2019s current expectations, but actual results may differ materially due to various risks and uncertainties, including, but not limited to, potential difficulties or delays in the development, testing, regulatory approvals for trial commencement, progression or product sale or manufacturing of Cytokinetics\u2019 drug candidates that could slow or prevent clinical development or product approval; Cytokinetics\u2019 drug candidates may have adverse side effects or inadequate therapeutic efficacy; the FDA or foreign regulatory agencies may delay or limit Cytokinetics\u2019 ability to conduct clinical trials; Cytokinetics may be unable to obtain or maintain patent or trade secret protection for its intellectual property; standards of care may change, rendering Cytokinetics\u2019 drug candidates obsolete; and competitive products or alternative therapies may be developed by others for the treatment of indications Cytokinetics\u2019 drug candidates and potential drug candidates may target. For further information regarding these and other risks related to Cytokinetics\u2019 business, investors should consult Cytokinetics\u2019 filings with the Securities and Exchange Commission.<\/p>\n<p align=\"justify\">CYTOKINETICS\u00ae and the CYTOKINETICS C-shaped logo are registered trademarks of Cytokinetics in the U.S. and certain other countries.<\/p>\n<p align=\"justify\">MYQORZO\u00ae is a registered trademark of Cytokinetics in the U.S., the European Union, the United Kingdom and Canada.<\/p>\n<p>Contact:<br \/>Cytokinetics<br \/>Diane Weiser<br \/>Senior Vice President, Corporate Affairs<br \/>(415) 290-7757<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTA2M2UzZWEtYjNmYy00ZWFjLTgyMmQtNWEzYWUzYjU5MDZjLTEwMTY2NzYtMjAyNi0xMS0wMi1lbg==\/tiny\/Cytokinetics-Incorporated.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three upcoming presentations, including two Late Breaking Oral Abstract presentations and one poster presentation, at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions, held in collaboration with the American Heart Association Scientific Sessions, taking place in Chicago, IL, November 6, 2026. Late-Breaking Oral Abstracts Title: Effect of Aficamten on Cardiac Structure and Function in Nonobstructive Hypertrophic Cardiomyopathy: The ACACIA-HCM CMR Study Presenter: Ahmad Masri, M.D., M.S., Associate Professor of Medicine, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health &amp; Science UniversityDate: Friday, November 6, 2026Session Title: Session 4 &#8211; Late Breaking Oral AbstractsSession Time: 2:15 PM \u2013 3:15 PM CT Presentation Time: 2:30 PM &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1016060","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three upcoming presentations, including two Late Breaking Oral Abstract presentations and one poster presentation, at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions, held in collaboration with the American Heart Association Scientific Sessions, taking place in Chicago, IL, November 6, 2026. Late-Breaking Oral Abstracts Title: Effect of Aficamten on Cardiac Structure and Function in Nonobstructive Hypertrophic Cardiomyopathy: The ACACIA-HCM CMR Study Presenter: Ahmad Masri, M.D., M.S., Associate Professor of Medicine, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health &amp; Science UniversityDate: Friday, November 6, 2026Session Title: Session 4 &#8211; Late Breaking Oral AbstractsSession Time: 2:15 PM \u2013 3:15 PM CT Presentation Time: 2:30 PM &hellip; Continue reading &quot;Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-02T14:37:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026\",\"datePublished\":\"2026-11-02T14:37:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/\"},\"wordCount\":735,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/\",\"name\":\"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=\",\"datePublished\":\"2026-11-02T14:37:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/","og_locale":"en_US","og_type":"article","og_title":"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Calif., Nov. 02, 2026 (GLOBE NEWSWIRE) &#8212; Cytokinetics, Incorporated (Nasdaq: CYTK) today announced three upcoming presentations, including two Late Breaking Oral Abstract presentations and one poster presentation, at the Hypertrophic Cardiomyopathy Medical Society Scientific Sessions, held in collaboration with the American Heart Association Scientific Sessions, taking place in Chicago, IL, November 6, 2026. Late-Breaking Oral Abstracts Title: Effect of Aficamten on Cardiac Structure and Function in Nonobstructive Hypertrophic Cardiomyopathy: The ACACIA-HCM CMR Study Presenter: Ahmad Masri, M.D., M.S., Associate Professor of Medicine, Director of the Hypertrophic Cardiomyopathy Center at Oregon Health &amp; Science UniversityDate: Friday, November 6, 2026Session Title: Session 4 &#8211; Late Breaking Oral AbstractsSession Time: 2:15 PM \u2013 3:15 PM CT Presentation Time: 2:30 PM &hellip; Continue reading \"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-02T14:37:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026","datePublished":"2026-11-02T14:37:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/"},"wordCount":735,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/","name":"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=","datePublished":"2026-11-02T14:37:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg2NzcwMyM3OTM4Nzk0IzIwMDUxMDM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytokinetics-announces-three-upcoming-presentations-at-the-hypertrophic-cardiomyopathy-medical-society-hcms-scientific-sessions-held-in-collaboration-with-the-american-heart-association-scientific-s\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Cytokinetics Announces Three Upcoming Presentations at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions Held in Collaboration with the American Heart Association Scientific Sessions 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016060","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1016060"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1016060\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1016060"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1016060"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1016060"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}